This week’s startup analysis highlights a division in AI applications: one side focuses on compliance tools for regulatory challenges, while the other explores creative uses like digital art from brainwaves. Notable companies include RootTrust, which addresses PBM contract risks, and Synapse, which creates art from neural data.

• Startups are splitting into two camps: compliance-focused AI (RootTrust, ValidTrace, LokalGrid) versus creative/experimental AI (AxonGrid, Synapse, Sentia)
• RootTrust and ValidTrace target pharma-specific regulatory risk, with ValidTrace positioning around the EU's tightening AI rules
• Synapse and AxonGrid are turning neural/brainwave data into new territory—generative art and virtual neuron experiments, respectively
• Coval is building a platform for co-living among older adults, reflecting shifting attitudes toward aging and companionship